A substrate-competition hypothesis for type 2 diabetes driven by nutrient excess rather than a primary insulin-signaling defect

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Medical Hypotheses

• Publication date

  2026-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.mehy.2026.111926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of Total, Diagnosed, and Undiagnosed Diabetes in Adults: United States, August 2021-August 2023.

  2024cited by this paper
• Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic.

  2023cited by this paper
• Economic Costs of Diabetes in the U.S. in 2022.

  2023cited by this paper
• Safety and efficacy of very low carbohydrate diet in patients with diabetic kidney disease—A randomized controlled trial

  2021cited by this paper
• Insulin Signal Transduction Perturbations in Insulin Resistance

  2021cited by this paper
• Pathophysiology of Type 2 Diabetes Mellitus

  2020cited by this paper
• Metabolically Healthy Obesity

  2020cited by this paper
• What lipodystrophies teach us about the metabolic syndrome.

  2019cited by this paper
• Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis

  2019cited by this paper
• Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study

  2018cited by this paper
• Ethnic differences in the prevalence of diabetes in underweight and normal weight individuals: The CARRS and NHANES studies.

  2018cited by this paper
• Projection of the future diabetes burden in the United States through 2060

  2018cited by this paper
• Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.

  2017cited by this paper
• Normal weight individuals who develop type 2 diabetes: the personal fat threshold.

  2015cited by this paper
• Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease.

  2014cited by this paper
• Maternal outcomes and follow‐up after gestational diabetes mellitus

  2014cited by this paper
• Exercise, GLUT4, and skeletal muscle glucose uptake.

  2013cited by this paper
• Reduction in urinary albumin excretion with a moderate low-carbohydrate diet in patients with type 2 diabetes: a 12-month intervention

  2012cited by this paper
• Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol

  2011cited by this paper
• Lipodystrophies: Genetic and Acquired Body Fat Disorders

  2011cited by this paper
• Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

  2010cited by this paper
• Dynamics of fat cell turnover in humans

  2008cited by this paper
• Adipose tissue expandability and the metabolic syndrome

  2007cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Genetics of type 2 diabetes mellitus.

  2005cited by this paper
• Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors.

  2005cited by this paper
• The selfish brain: competition for energy resources.

  2004cited by this paper
• Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.

  2004cited by this paper
• Mechanism of free fatty acid-induced insulin resistance in humans.

  1996cited by this paper
• The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM

  1988cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper

• No citing papers are available for this paper.